{
    "title": "More Eisai/Biogen Alzheimer's drug approvals seen likely despite safety warning",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12276039/More-Eisai-Biogen-Alzheimers-drug-approvals-seen-likely-despite-safety-warning.html",
    "date": "2023-07-07",
    "keywords": [
        "drug",
        "approval",
        "fda",
        "leqembi",
        "europe",
        "year",
        "suit",
        "safety",
        "analyst",
        "bhanvi",
        "satija",
        "risk",
        "brain",
        "swelling",
        "biogen",
        "japan",
        "decision",
        "blair",
        "agency",
        "ema",
        "trade",
        "capital",
        "brokerage",
        "reporting",
        "july",
        "eisais",
        "street",
        "health",
        "share",
        "side",
        "effect",
        "food",
        "administration",
        "thursday",
        "chemical",
        "name",
        "union",
        "china",
        "britain",
        "end",
        "september",
        "dunk",
        "reception",
        "opinion",
        "agencys",
        "committee",
        "minter",
        "fdas",
        "trial",
        "meeting",
        "month",
        "friday",
        "warning",
        "surprise",
        "eisai",
        "bmo",
        "seigerman",
        "unsure",
        "timeline",
        "point",
        "ami",
        "fadia",
        "peak",
        "forecast",
        "research",
        "canaccord",
        "genuity",
        "truist",
        "deena",
        "beasley",
        "editing",
        "humer",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}